News & Resources

SEC Filings

<< Back
Form 8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 03/30/2017
Document Outline
Entire Document (229.2 KB)
Subdocument 1 - 8-K - 8-K
Page 1 - UNITED STATES
Page 2 - Item 9.01 Financial Statements and Exhibits.
Page 3 - SIGNATURES
Subdocument 2 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - N/A
Subdocument 3 - EX-10.1 - EX-10.1
Page 1 - Exhibit 10.1
Page 2 - Prospectus Supplement
Page 3 - Section 12
Page 4 - Suspension
Page 5 - Section 10(a)
Page 6 - No Misstatement or Omission
Page 7 - Financial Information
Page 8 - Subsidiaries
Page 9 - Authorization; Enforceability
Page 10 - EY
Page 11 - IND
Page 12 - Intellectual Property
Page 13 - Non-Affiliate Shares
Page 14 - Title to Real and Personal Property
Page 15 - Evaluation Date
Page 16 - Finder s Fees
Page 17 - Forward-Looking Statement
Page 18 - Status Under the Securities Act
Page 19 - Person
Page 20 - Occupational Laws
Page 21 - provided
Page 22 - provided, however,
Page 23 - Use of Proceeds
Page 24 - Representation Dates; Certificate
Page 25 - Section 7(l)
Page 26 - Market Activities
Page 27 - Secretary s Certificate; Further Documentation
Page 28 - Conditions to Agent s Obligations
Page 29 - Legal Opinion
Page 30 - Indemnification and Contribution
Page 31 - Agent Information
Page 32 - Contribution
Page 33 - Section 10(d)
Page 34 - Section 8
Page 35 - Notices
Page 36 - Business Day
Page 37 - WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIF
Page 38 - Permitted Free Writing Prospectuses
Page 39 - Definitions
Page 40 - N/A
Page 41 - SCHEDULE 1
Page 42 - SCHEDULE 2
Page 43 - SCHEDULE 3
Page 44 - Form of Representation Date Certificate Pursuant to Section 7(l)
Page 45 - Exhibit 21